Crinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters More

A director of Crinetics Pharmaceuticals sold 5,000 shares for approximately $180,761 on March 12, 2026. The ~$180.8k insider sale is a routine disclosure and is unlikely to materially affect the company's stock.

Analysis

A director of Crinetics Pharmaceuticals sold 5,000 shares for approximately $180,761 on March 12, 2026. The ~$180.8k insider sale is a routine disclosure and is unlikely to materially affect the company's stock.